Currently, several biomarkers are utilized for the diagnosis and prognostic evaluation of acute myocardial infarction (AMI), including cardiac troponin I (TnI), creatine kinase (CK), and N-terminal pro-b-type natriuretic peptide (NT-proBNP). Here, TNNI3 is linked to myocardial infarction.